Phloroglucinol Inhibits Oxidative-Stress-Induced Cytotoxicity in C2C12 Murine Myoblasts through Nrf-2-Mediated Activation of HO-1open access
- Authors
- Park, C.; Cha, H.-J.; Hwangbo, H.; Ji, S.Y.; Kim, D.H.; Kim, M.Y.; Bang, E.; Hong, S.H.; Kim, S.O.; Jeong, S.-J.; Lee, H.; Moon, S.-K.; Shim, J.-H.; Kim, G.-Y.; Cho, S.; Choi, Y.H.
- Issue Date
- Mar-2023
- Publisher
- MDPI
- Keywords
- apoptosis; DNA damage; Nrf2/HO-1; phloroglucinol; ROS
- Citation
- International Journal of Molecular Sciences, v.24, no.5
- Journal Title
- International Journal of Molecular Sciences
- Volume
- 24
- Number
- 5
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/68241
- DOI
- 10.3390/ijms24054637
- ISSN
- 1661-6596
1422-0067
- Abstract
- Phloroglucinol is a class of polyphenolic compounds containing aromatic phenyl rings and is known to have various pharmacological activities. Recently, we reported that this compound isolated from Ecklonia cava, a brown alga belonging to the family Laminariaceae, has potent antioxidant activity in human dermal keratinocytes. In this study, we evaluated whether phloroglucinol could protect against hydrogen peroxide (H2O2)-induced oxidative damage in murine-derived C2C12 myoblasts. Our results revealed that phloroglucinol suppressed H2O2-induced cytotoxicity and DNA damage while blocking the production of reactive oxygen species. We also found that phloroglucinol protected cells from the induction of apoptosis associated with mitochondrial impairment caused by H2O2 treatment. Furthermore, phloroglucinol enhanced the phosphorylation of nuclear factor-erythroid-2 related factor 2 (Nrf2) as well as the expression and activity of heme oxygenase-1 (HO-1). However, such anti-apoptotic and cytoprotective effects of phloroglucinol were greatly abolished by the HO-1 inhibitor, suggesting that phloroglucinol could increase the Nrf2-mediated activity of HO-1 to protect C2C12 myoblasts from oxidative stress. Taken together, our results indicate that phloroglucinol has a strong antioxidant activity as an Nrf2 activator and may have therapeutic benefits for oxidative-stress-mediated muscle disease. © 2023 by the authors.
- Files in This Item
-
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/68241)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.